New Urine Test could diagnose pancreatic cancer super early

Nearly 200 urine samples were collected from patients with pancreatic cancer and were compared with around 100 samples taken from individuals with chronic pancreatitis. About as many samples were also taken from healthy people for a study by researchers from Barts Cancer Institute at Queen Mary University of London.

Three proteins – LYVE1, REG1A and TFF1 – were observed at significantly elevated levels in the urine samples produced by pancreatic cancer patients. Levels of the proteins were found to be much lower in the patients with chronic pancreatitis. [1]

Researchers were able to use their findings to diagnose stage 1 and 2 pancreatic cancer in urine samples with more than 90% accuracy. The non-invasive, inexpensive test could save many more lives. [1]